Literature DB >> 11216921

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.

Y D Mukadi, D Maher, A Harries.   

Abstract

BACKGROUND: Tuberculosis is a leading cause worldwide of morbidity and mortality among HIV-infected people. The HIV era has seen a dramatic increase of the tuberculosis case fatality rate (CFR) in high HIV prevalence populations. Providing care for HIV-infected people must include measures to tackle this high tuberculosis CFR. AIMS: To analyse the extent of the increased tuberculosis CFR in high HIV prevalence populations in sub-Saharan Africa, the reasons for this increase and the causes of death, in order to identify possible ways of tackling this problem.
METHODS: References were obtained by searching the MEDLINE on 'tuberculosis', 'HIV infection', and 'mortality' (MesH or textword). In addition, available data from National Tuberculosis Programme reports were reviewed.
FINDINGS: Tuberculosis CFR is closely linked to HIV prevalence. Limited autopsy data suggest that death from HIV-related diseases other than tuberculosis is probably the main reason for the increased CFR in HIV-infected tuberculosis patients. Among HIV-infected tuberculosis patients, the higher tuberculosis CFR in sputum smear-negative and extrapulmonary than in sputum smear-positive tuberculosis cases can also be attributed to misdiagnosis of HIV-related diseases as tuberculosis. The adverse effect of the HIV/AIDS epidemic on general health service performance probably accounts for the higher tuberculosis CFR among HIV-negative tuberculosis patients in high prevalence populations than that in low HIV-prevalence populations.
CONCLUSION: Tackling the problem of the increased tuberculosis CFR in high HIV prevalence populations requires collaboration between tuberculosis control and HIV/AIDS programmes in implementing measures such as improved health services, tuberculosis and HIV control services, preventive treatment for HIV-related diseases and anti-HIV treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11216921     DOI: 10.1097/00002030-200101260-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  108 in total

1.  Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania.

Authors:  K Kawai; E Villamor; F M Mugusi; E Saathoff; W Urassa; R J Bosch; D Spiegelman; W W Fawzi
Journal:  Int J Tuberc Lung Dis       Date:  2011-10       Impact factor: 2.373

2.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

Review 3.  HIV and tuberculosis coinfection: inextricably linked liaison.

Authors:  Vincent Idemyor
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

4.  Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.

Authors:  François-Xavier Blanc; Thim Sok; Didier Laureillard; Laurence Borand; Claire Rekacewicz; Eric Nerrienet; Yoann Madec; Olivier Marcy; Sarin Chan; Narom Prak; Chindamony Kim; Khemarin Kim Lak; Chanroeurn Hak; Bunnet Dim; Chhun Im Sin; Sath Sun; Bertrand Guillard; Borann Sar; Sirenda Vong; Marcelo Fernandez; Lawrence Fox; Jean-François Delfraissy; Anne E Goldfeld
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

5.  Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.

Authors:  Vivian Kawai; Giselle Soto; Robert H Gilman; Christian T Bautista; Luz Caviedes; Luz Huaroto; Eduardo Ticona; Jaime Ortiz; Marco Tovar; Victor Chavez; Richard Rodriguez; A Roderick Escombe; Carlton A Evans
Journal:  Am J Trop Med Hyg       Date:  2006-12       Impact factor: 2.345

Review 6.  A systematic review of published literature describing factors associated with tuberculosis recurrence in people living with HIV in Africa.

Authors:  Yoshan Moodley; Kumeren Govender
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

7.  Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi.

Authors:  Kashmira S Chawla; Cecilia Kanyama; Abineli Mbewe; Mitch Matoga; Irving Hoffman; Jonathan Ngoma; Mina C Hosseinipour
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-05       Impact factor: 2.184

8.  Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.

Authors:  Ferdinand M Mugusi; Saurabh Mehta; Eduardo Villamor; Willy Urassa; Elmar Saathoff; Ronald J Bosch; Wafaie W Fawzi
Journal:  BMC Public Health       Date:  2009-11-12       Impact factor: 3.295

9.  Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma.

Authors:  Jann-Yuan Wang; Chien-Hong Chou; Li-Na Lee; Hsiao-Leng Hsu; I-Shiow Jan; Po-Ren Hsueh; Pan-Chyr Yang; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

10.  Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.

Authors:  Somsak Akksilp; Opart Karnkawinpong; Wanpen Wattanaamornkiat; Daranee Viriyakitja; Patama Monkongdee; Walya Sitti; Dhanida Rienthong; Taweesap Siraprapasiri; Charles D Wells; Jordan W Tappero; Jay K Varma
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.